Northwestern Mutual Wealth Management Co. Has $72.88 Million Position in Intuitive Surgical, Inc. $ISRG

Northwestern Mutual Wealth Management Co. grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.6% during the 4th quarter, Holdings Channel reports. The firm owned 128,681 shares of the medical equipment provider’s stock after purchasing an additional 11,294 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Intuitive Surgical were worth $72,880,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in ISRG. Assenagon Asset Management S.A. lifted its holdings in Intuitive Surgical by 106.6% during the 4th quarter. Assenagon Asset Management S.A. now owns 1,533,771 shares of the medical equipment provider’s stock valued at $868,667,000 after purchasing an additional 791,516 shares during the last quarter. Amundi increased its holdings in shares of Intuitive Surgical by 29.7% during the third quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock worth $1,451,362,000 after buying an additional 739,444 shares in the last quarter. Sands Capital Management LLC raised its stake in shares of Intuitive Surgical by 77.0% in the third quarter. Sands Capital Management LLC now owns 1,341,109 shares of the medical equipment provider’s stock valued at $599,784,000 after acquiring an additional 583,539 shares during the last quarter. Victory Capital Management Inc. raised its stake in shares of Intuitive Surgical by 41.3% in the third quarter. Victory Capital Management Inc. now owns 1,941,310 shares of the medical equipment provider’s stock valued at $868,212,000 after acquiring an additional 567,483 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in shares of Intuitive Surgical by 185.4% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 674,495 shares of the medical equipment provider’s stock worth $301,654,000 after acquiring an additional 438,200 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Wall Street optimism is supporting the stock, with one article arguing Intuitive Surgical could rise more than 30% from current levels because analysts believe the long-term growth story remains intact and the recent selloff has created an attractive entry point. Article Title
• Positive Sentiment: Intuitive Surgical announced a leadership change in commercial and marketing, promoting Taylor Patton to Chief Commercial and Marketing Officer effective July 1, which may be viewed as a continuity move that could support execution and sales strategy. Article Title
• Neutral Sentiment: Market commentary noted the stock is still trading well below its recent high, underscoring that investor caution remains elevated even though the company continues to be viewed as a leader in robotic-assisted surgery. Article Title
• Neutral Sentiment: Third-party market reports described ISRG as underperforming peers and highlighted recent short-interest data, but the figures did not show a clear new bearish catalyst. Article Title
• Neutral Sentiment: Intuitive Surgical also appeared in broader “physical AI” and robotics commentary, which is more of a thematic mention than a company-specific catalyst for the stock. Article Title

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction on Monday, May 11th. The shares were sold at an average price of $446.95, for a total value of $178,780.00. Following the sale, the executive vice president directly owned 6,120 shares in the company, valued at approximately $2,735,334. The trade was a 6.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 500 shares of the business’s stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total transaction of $236,730.00. Following the sale, the director directly owned 239 shares in the company, valued at $113,156.94. This trade represents a 67.66% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 5,481 shares of company stock valued at $2,673,871 over the last three months. 0.60% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Up 0.2%

Shares of NASDAQ ISRG opened at $424.59 on Friday. Intuitive Surgical, Inc. has a 1 year low of $414.30 and a 1 year high of $603.88. The firm’s 50-day moving average is $453.54 and its 200-day moving average is $506.43. The firm has a market capitalization of $150.37 billion, a PE ratio of 51.47, a price-to-earnings-growth ratio of 3.38 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The company had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. During the same period in the previous year, the company earned $1.81 EPS. The company’s revenue for the quarter was up 23.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on ISRG shares. HSBC dropped their price target on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Raymond James Financial decreased their target price on Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating on the stock in a report on Wednesday, April 22nd. TD Cowen lowered their target price on Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Jefferies Financial Group reduced their price target on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a research report on Wednesday, April 22nd. Finally, Piper Sandler lowered their price objective on shares of Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Nineteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $576.71.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.